University of Toronto - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
29 Pages - GLDATA58419
$250.00

Summary

University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university provides courses in various fields,which include applied science and engineering, architecture, landscape, design, arts and science, continuing studies, school of dentistry education, forestry education, arts, science and business, music, physical education and health, law, medical radiation sciences, medicine, nursing, pharmacy, biochemistry, biology, cell and systems biology, chemical and physical sciences. It conducts research and development on the areas of psychology, biology, public health sciences, environment sciences and Alzheimer diseases. The university partners with researchers, government and industries across Brazil and Italy for its research activities. UT is headquartered in Toronto, Ontario, Canada.

University of Toronto - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Toronto, Medical Devices Deals, 2010 to YTD 2016 9
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of Toronto, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Celgene Partners with Recombinant Antibody Network 12
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 16
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 17
Licensing Agreements 18
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 18
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Cardium Therapeutics Enters Into Licensing Agreement With University of Toronto 22
Asset Transactions 23
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 25
University of Toronto - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
University of Toronto, Pharmaceuticals & Healthcare, Key Facts 1
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Toronto, Deals By Therapy Area, 2010 to YTD 2016 8
University of Toronto, Medical Devices Deals, 2010 to YTD 2016 9
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Celgene Partners with Recombinant Antibody Network 12
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 16
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 17
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 18
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Cardium Therapeutics Enters Into Licensing Agreement With University of Toronto 22
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 25
University of Toronto, Key Competitors 26
University of Toronto, Key Employees 27
University of Toronto, Other Locations 28
University of Toronto, Subsidiaries 28

List of Figures
University of Toronto, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Toronto, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Toronto, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838